Arax Advisory Partners’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$166K Buy
931
+77
+9% +$12.6K ﹤0.01% 2447
2026
Q2
$128K Buy
854
+392
+85% +$42.6K ﹤0.01% 2553
2026
Q1
$43.6K Sell
462
-271
-37% -$27.2K ﹤0.01% 1742
2025
Q4
$74.9K Buy
733
+279
+61% +$25K ﹤0.01% 1438
2025
Q3
$28.4K Buy
454
+344
+313% +$18.7K ﹤0.01% 2111
2025
Q2
$5.72K Hold
110
– – ﹤0.01% 2196
2025
Q1
$4.69K Buy
110
+60
+120% +$2.59K ﹤0.01% 1804
2024
Q4
$1.53K Sell
50
-34
-40% -$956 ﹤0.01% 2072
2024
Q3
$1.93K Hold
84
– – ﹤0.01% 2077
2024
Q2
$2.43K Buy
84
+34
+68% +$792 ﹤0.01% 1897
2024
Q1
$1.03K Sell
50
-50
-50% -$1.07K ﹤0.01% 1150
2023
Q4
$2.71K Hold
100
– – ﹤0.01% 979
2023
Q3
$2.96K Hold
100
– – ﹤0.01% 964
2023
Q2
$3.58K Hold
100
– – ﹤0.01% 926
2023
Q1
$2.34K Hold
100
– – ﹤0.01% 980
2022
Q4
$2.72K Hold
100
– – ﹤0.01% 910
2022
Q3
$5K Hold
100
– – ﹤0.01% 799
2022
Q2
$4K Hold
100
– – ﹤0.01% 824
2022
Q1
$7K Hold
100
– – ﹤0.01% 704
2021
Q4
$10K Hold
100
– – ﹤0.01% 656
2021
Q3
$13K Hold
100
– – ﹤0.01% 605
2021
Q2
$12K Buy
+100
New +$13.5K ﹤0.01% 635
2020
Q4
$13K Hold
100
– – ﹤0.01% 540
2020
Q3
$11K Hold
100
– – ﹤0.01% 530
2020
Q2
$8K Hold
100
– – ﹤0.01% 554
2020
Q1
$7K Buy
+100
New +$7.67K ﹤0.01% 546

Other funds holding GH

Arax Advisory Partners's GH Position: Q3 2026 in Review

Arax Advisory Partners increased its Guardant Health (GH) stake by 9% in Q3 2026, buying an estimated $12.6K and bringing the position to 931 shares worth $166K. The position accounts for ﹤0.01% of the portfolio, ranked #2447.

Arax Advisory Partners first reported a position in GH in Q1 2020 and has held it in 26 quarters since. 673 funds tracked by Wall St. Rank hold GH as of Q3 2026.

  • Arax Advisory Partners held 931 shares of Guardant Health worth $166K as of Q3 2026.
  • Arax Advisory Partners bought 77 Guardant Health shares in Q3 2026, an estimated $12.6K.
  • Guardant Health made up ﹤0.01% of Arax Advisory Partners's portfolio in Q3 2026, its #2447 holding.
  • Arax Advisory Partners first reported a position in Guardant Health in Q1 2020 and has held it in 26 quarters since.
  • 673 funds tracked by Wall St. Rank held Guardant Health as of Q3 2026.

Based on Arax Advisory Partners's 13F filing for Q3 2026, filed 12 Nov 2026.